₹0.65
(Market cap
₹5 Cr
Revenue (TTM)
₹2 Cr
P/E Ratio
46.6
P/B Ratio
-11.2
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹0 Cr
-
ROE
0 %
-
ROCE
2.5 %
-
Industry P/E
51.79
-
EV/EBITDA
182.6
-
Debt to Equity
-9.8
-
Book Value
₹-1.2
-
EPS
₹0.3
-
Face value
10
-
Shares outstanding
3,465,900
10 Years Aggregate
CFO
₹-2.55 Cr
EBITDA
₹-0.87 Cr
Net Profit
₹-1.46 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Hemo Organic
| -20.2 | 15.2 | 3.5 | 45.2 | 11.8 | 2.7 | -2.4 |
|
BSE Healthcare
| 6.3 | 8.3 | 7.1 | 10.9 | 25.9 | 13.6 | 11.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|---|
|
Hemo Organic
| 50.3 | 58.1 | -26.7 | 31.8 | -45.7 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Hemo Organic
|
13.7 | 4.8 | 2.4 | 0.1 | -2.4 | -- | 46.6 | -11.2 |
| 3,123.2 | 39,079.9 | 5,452.9 | 1,056.0 | 22.4 | 23.9 | 37 | 8.6 | |
| 6.2 | 7.4 | 0.5 | -0.1 | -89.9 | -- | -- | 0.6 | |
| 26.0 | 14.8 | 8.0 | 0.6 | 13.8 | 5.5 | 23.5 | 1.2 | |
| 1,657.0 | 31,456.7 | 9,203.5 | 941.3 | 15.4 | 19.6 | 34 | 6.4 | |
| 2,094.3 | 33,637.1 | 4,147.8 | 709.5 | 22.3 | 18.3 | 47.4 | 8.1 | |
| 214.6 | 283.2 | 127.7 | -24.3 | -20.8 | -325.5 | -- | 56.7 | |
| 21.3 | 36.6 | 49.3 | 0.8 | 1.6 | 4.5 | 48.2 | 2.1 | |
| 37.5 | 36.0 | 69.9 | 1.8 | 3.3 | 4.1 | 20.4 | 1.0 | |
| 108.2 | 69.7 | 65.4 | 2.8 | 6.6 | 12.1 | 25 | 2.8 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Hemo Organic
Manufacture of ayurvedic' or unani' pharmaceutical preparation
-
Incorporated
1992
-
Chairman
--
-
Managing Director
Vishwambar Kameshwar Singh
-
Headquarters
Ahmedabad, Gujarat
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
FAQs for Hemo Organic
What is the current share price of Hemo Organic Ltd Today?
The share price of Hemo Organic Ltd is ₹13.71 (BSE) as of 13-May-2026 IST. Hemo Organic Ltd has given a return of 11.84% in the last 3 years.
What is the current PB & PE ratio of Hemo Organic Ltd?
The P/E ratio of Hemo Organic Ltd is 46.59 times as on 13-May-2026, a 10 discount to its peers’ median range of 51.79 times.
The P/B ratio of Hemo Organic Ltd is -11.25 times as on 13-May-2026, a 136 discount to its peers’ median range of 30.83 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
18.97
|
-20.52
|
|
2024
|
0.00
|
-11.21
|
|
2023
|
0.00
|
-48.06
|
|
2022
|
0.00
|
5,177.65
|
|
2021
|
0.00
|
76.90
|
What is the 52 Week High and Low of Hemo Organic Ltd?
The 52-week high and low of Hemo Organic Ltd are Rs 22.51 and Rs 8.08 as of 13-May-2026.
What is the market cap of Hemo Organic Ltd?
Hemo Organic Ltd has a market capitalisation of ₹ 5 Cr as on 13-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Hemo Organic Ltd?
Before investing in Hemo Organic Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.